Safety and efficacy of l‐lysine monohydrochloride and concentrated liquid l‐lysine (base) produced by fermentation using Corynebacterium glutamicum strain NRRL B‐50775 for all animal species based on a dossier submitted by ADM

The European Commission asked EFSA for an opinion on the safety for the target animals, consumer, user and the environment and on the efficacy of a l‐lysine monohydrochloride (HCl, minimum 98.5%) and of a concentrated liquid l‐lysine (base, minimum 50%) produced by a genetically modified strain of C...

Descripción completa

Detalles Bibliográficos
Autores principales: Bampidis, Vasileios, Azimonti, Giovanna, Bastos, Maria de Lourdes, Christensen, Henrik, Dusemund, Birgit, Kouba, Maryline, Kos Durjava, Mojca, López‐Alonso, Marta, López Puente, Secundino, Marcon, Francesca, Mayo, Baltasar, Pechová, Alena, Petkova, Mariana, Ramos, Fernando, Sanz, Yolanda, Villa, Roberto Edoardo, Woutersen, Ruud, Costa, Lucio, Dierick, Noël, Flachowsky, Gerhard, Glandorf, Boet, Herman, Lieve, Kärenlampi, Sirpa, Mantovani, Alberto, Aguilera, Jaime, Anguita, Montserrat, Tarrés‐Call, Jordi, Wallace, Robert John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Scientific Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7009140/
https://www.ncbi.nlm.nih.gov/pubmed/32626082
http://dx.doi.org/10.2903/j.efsa.2019.5537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7009140/
https://www.ncbi.nlm.nih.gov/pubmed/32626082
http://dx.doi.org/10.2903/j.efsa.2019.5537

Ejemplares similares